Overview
Dr. Hughes serves as Medical Director for Johns Hopkins Medicine’s Office of Telemedicine and Medical Director of Pediatric Telemedicine for the Johns Hopkins Children’s Center. She is a medical informaticist and co-chairs the Johns Hopkins Patient Family Centered Design (MyChart) committee. Dr. Hughes is an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine. After earning an undergraduate degree at Haverford College, Dr. Hughes attended medical school at Johns Hopkins School of Medicine and received a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health. She completed a residency in pediatrics and served as Chief Resident at Johns Hopkins, where she stayed on to complete a research fellowship in General Academic Pediatrics. Dr. Hughes is the co-editor of the Harriet Lane Handbook, 21st Edition, which is one of the most widely used pediatric handbooks nationally and internationally. She previously served as Associate Program Director for Pediatric residency training and the director of the Pediatric Residency Program Health Equity Track. Dr. Hughes is a national leader in the field of telemedicine and patient-facing digital health technologies. Dr. Hughes and team have won the AAMC’s Telehealth Equity Catalyst Award for three consecutive years (2022, 2023, and 2024). In 2023, Helen was selected to join the American Telemedicine Association’s Clinician Council – a group of approximately 35 clinician telehealth leaders who are developing clinical practice guidance for the nation’s leading telemedicine professional society. Recent News Articles and Media Coverage Coronavirus Triggers Telemedicine Acceleration, Johns Hopkins Medicine (April 30, 2020) Contact for Research Inquiries 200 N Wolfe Street Baltimore, MD 21287.
Dr. Hughes is board certified in American Board Of Pediatrics. She is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Graduate Institution
Residency
Specialties
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rubenstein Child Health Building
Dr. Julie Hoover-Fong is a Professor of Genetic Medicine and Pediatrics and Director of the Greenberg Center for Skeletal Dysplasias at Johns Hopkins University. Dr. Hoover-Fong holds a bachelor’s degree in Human Nutrition from The Ohio State University, where she also completed her medical degree. She received her Ph.D. in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Hoover-Fong completed a pediatric internship and residency at Washington University in St. Louis and a fellowship in medical genetics at Johns Hopkins University in Baltimore. She joined the Johns Hopkins University faculty in 2002 and progressed to Professor of Genetic Medicine and Pediatrics in 2019. She practices and oversees the clinical operations, research and educational ventures for the patients, families and healthcare providers served by the Greenberg Center. Her clinical team develops and improves diagnostic and treatment guidelines for comprehensive care of patients with all types of bone conditions including dwarfism, orofacial clefting, craniosynostosis and more. Dr. Hoover-Fong also mentors and teaches medical students, residents and genetic medicine trainees. As an active clinical researcher, Dr. Hoover-Fong is the Principal Investigator of multiple global clinical trials for achondroplasia, the first multi-center, investigator-initiated natural history study for achondroplasia, and multiple clinical studies for patients with orofacial clefting, hypophosphatasia and other conditions. She is also a co-investigator on the ELSI and Phenotype Review Committees for the Mendel Project, a whole exome sequencing venture to identify the genetic cause of Mendelian conditions. From an institutional service perspective, Dr. Hoover-Fong serves on the Johns Hopkins Associate Professor Promotions Committee and the Advisory Committee for the Graduate Training Program in Clinical Investigation. She serves on the Medical Advisory Board of the Little People of America, is a member of the Miller-Coulson Academy of Clinical Excellence at Johns Hopkins University and is a charter member of the International Skeletal Dysplasia Management Consortium, publishing best practice guidelines for patients with skeletal dysplasias. Dr. Hoover is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Achondroplasia, Rhizomelic Syndrome, Spondyloepimetaphyseal Dysplasia Strudwick Type, Adenoidectomy, and Myringotomy. Dr. Hoover is board certified in American Board Of Medical Genetics And Genomics.
BMS At Yard 56
Dr. Lauren Melissa Jansson is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include drug abuse research, drug-exposed infants and children, and pediatrics. Dr. Jansson earned her M.D. from the State University of New York at Downstate Medical Center. She completed her residency at the Children’s Hospital at Albany Medical Center and performed a fellowship in developmental pediatrics at the Albert Einstein College of Medicine. Her research interests include fetal neurobehavioral development in drug-exposed pregnancies, lactation in opioid-dependent women on medication assisted treatment, and neonatal abstinence syndrome resulting from in utero opiate and other substance exposures. Dr. Jansson is a member of several professional organizations, including the College on Problems of Drug Dependence, the Academic Pediatric Association, and the Society for Pediatric Research. Dr. Jansson is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Neonatal Abstinence Syndrome. Dr. Jansson is board certified in American Board Of Pediatrics.
Johns Hopkins Outpatient Center
Catherine Chu is the director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center in the Johns Hopkins Department of Neurology, as well as the vice president of child neurology at the Kennedy Krieger Institute. As a child neurologist, epileptologist and clinical neurophysiologist, Dr. Chu cares for children diagnosed with epilepsy and disorders of the nervous system (neurophysiology). She specializes in electroencephalogram (also known as EEG) analysis, seizure localization, surgical planning and neuromodulation for adult and pediatric patients with difficult to control epilepsy. She is nationally and internationally recognized for her work identifying causes of and treatment options for cognitive dysfunction and seizures in epilepsy and neurodevelopmental disorders. Dr. Chu’s team specializes in identifying and developing tools to detect and understand brain rhythms that support complex cognitive functions throughout development, including how these rhythms are disrupted by seizures and neurodevelopmental disorders. Dr. Chu earned her medical degree and a master’s degree in social anthropology from Harvard University. She completed an internship in pediatrics at Massachusetts General Hospital, and then a residency in neurology and child neurology at Massachusetts General and Brigham and Women’s Hospital. After completing two fellowships at Massachusetts General, one in epilepsy and another in clinical neurophysiology, Dr. Chu earned a master’s degree in medical science, focused on clinical investigation, from Harvard Medical School. Dr. Chu is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Benign Rolandic Epilepsy, Epilepsy in Children, Seizures, Epilepsy, and Deep Brain Stimulation. Dr. Chu is board certified in American Board Of Psychiatry And Neurology.
Frequently Asked Questions about Dr. Helen K. Hughes
How do I make an appointment with Dr. Helen K. Hughes?
You can book an appointment with Dr. Helen K. Hughes by calling their office at 410-955-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Does Dr. Helen K. Hughes accept my insurance?
Dr. Helen K. Hughes accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.